[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fugmxJo86GbIPTOcBSjxIHHt9VIN8zxkxgoWuktartXE":8,"$fK9G5Y93Mma-r2y5-VxPvLybEmuZbZZfCB0YFz2kFqRw":55,"$fnY27B17ddtTphCL4Uw3VyessDesIUvIdXJyfOBFGC04":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},68214,867283,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//o1oe1SwU3vlGsqy95secRlqRH2wkEV8k.png","王俊","烟台高新技术产业开发区医院","普通内科","主治医师",416,0,"结肠癌ⅢC期中分化腺癌化疗用药关键指南","","https://ystcdn.venuertc.com/venue/AI/929f0514-303e-41f6-a92f-9f64880412c3.jpg","\u003Cdiv class=\"material-medication-guide\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\">结肠癌ⅢC期中分化腺癌化疗用药关键指南\u003C/h1>\n  \n  \u003Cdiv class=\"material-section material-section-cover\" style=\"background: linear-gradient(90deg, #f6f7fb 20%, #e6e7f5 80%);\">\n    \u003Cp class=\"material-intro\">\n      提到结肠癌ⅢC期的中分化腺癌，化疗药物和辅助治疗往同时上阵。不少患者和家属最关心的，其实就是这些药品究竟该如何正确用、又该防哪些隐患。今天，就以本指南带来五类主流药物：\u003Cstrong>瑞戈非尼（靶向药）、头孢曲松（抗感染药）、胰岛素（辅助降糖药）、胃黏膜保护剂\u003C/strong>以及重点辅助化疗常见药物的实用要点详解。全篇会梳理出\u003Cstrong>7大关键用药细节\u003C/strong>，让大家用药不走弯路，远离风险。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003C!-- 01 靶向药物瑞戈非尼的安全使用指南 -->\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #f1f5f9 0%, #f9f6fa 100%)\">\n    \u003Ch2 class=\"material-subtitle\">\u003Cspan>01 🧬 瑞戈非尼（Regorafenib）的安全用法全解\u003C/span>\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cstrong>作用机制简介：\u003C/strong>瑞戈非尼属于多靶点酪氨酸激酶抑制剂，能干扰肿瘤细胞的生长信号通路，并影响肿瘤相关血管的生成，抑制肿瘤生长与扩散。\u003Cspan class=\"material-ref\">[Grothey A. et al., 2013, Lancet]\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确用法用量：\u003C/strong>建议在餐后用温水整片吞服，通常每日1次，具体剂量应由医生根据耐受性和副作用调整。避免空腹服用可减少胃肠道不适。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>特别提醒：\u003C/strong>服药期间不应自行增减剂量或断药。中断后如需重新开始，必须咨询专业医生或药师。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>常见不良反应：\u003C/strong>包括手足综合征、高血压、腹泻、皮疹、乏力。数据显示，皮肤不良反应发生率占30%以上，严重时须及时就医评估。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>用药相互作用：\u003C/strong>不可与强效CYP3A4抑制剂（如某些抗生素、抗真菌药等）合用，易增加药物毒性。慎用同时影响肝酶的药物。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>禁忌事项：\u003C/strong>严重肝功能损害者、妊娠及哺乳期妇女禁用。已知对瑞戈非尼成分过敏者禁止使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>储存方法：\u003C/strong>须置于干燥、避光、常温（20-25℃）处，开封后按盒上要求封闭保存。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>操作建议：\u003C/strong>发现药片颜色异常、异味、受潮即不得服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>漏服处理：\u003C/strong>若漏服，可在同一天内尽快补服；如已接近下一次服药时间，不需额外补服。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"material-case material-case-bg\">\n      \u003Cspan>实际用药经验：\u003C/span>一位中老年女性服用瑞戈非尼期间出现手足皮肤干裂，后调整护肤措施并减少刺激，皮肤问题得到缓解。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 02 常见辅助化疗药物用药讲解 -->\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #fbfaf6 0%, #fff9f2 80%)\">\n    \u003Ch2 class=\"material-subtitle\">\u003Cspan>02 💉 常用辅助化疗药物实际用法详解\u003C/span>\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cstrong>作用机制简介：\u003C/strong>如奥沙利铂、卡培他滨、氟尿嘧啶这类药物通过抑制肿瘤细胞的DNA合成，阻止其分裂和增殖，从而达到治疗效果。\u003Cspan class=\"material-ref\">[Van Cutsem E. et al., 2016, N Engl J Med]\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>使用与服药时间：\u003C/strong>大多数化疗药需在医院静脉输注，在医生指导下按疗程给药。口服药物（如卡培他滨）推荐餐后30分钟内服水送服，减少胃肠道刺激。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>特殊储存：\u003C/strong>口服化疗药需避光、防潮，密封存放；所有药品严格避免儿童接触。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>交互风险：\u003C/strong>化疗期间避免与抗酸药、大剂量维生素C、某些抗癫痫药等同服，否则可能影响疗效或增副作用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>常见副作用：\u003C/strong>骨髓抑制、白细胞下降、恶心、肠道反应较多见。骨髓抑制发生率可达40%以上，如发现明显疲乏应及时复查血象。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>禁忌事项：\u003C/strong>孕妇、哺乳期女性禁用。近期存在严重感染、出血风险者不宜服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>服药误区提示：\u003C/strong>勿自行加量、减量，严格履行医嘱，用药期间需关注身体变化。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"material-case material-case-bg\">\n      \u003Cspan>实际用药经验：\u003C/span>化疗患者采用分次递增剂量方案，副作用随剂量增加，调整后耐受性改善，未出现严重不良。全程在医护人员指导下配合检测。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 03 头孢曲松的使用流程与注意环节 -->\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #f6fbf7 0%, #eaf6eb 100%)\">\n    \u003Ch2 class=\"material-subtitle\">\u003Cspan>03 🦠 头孢曲松（Ceftriaxone）应用精要\u003C/span>\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cstrong>药理原理：\u003C/strong>属第三代头孢菌素，抑制细菌细胞壁合成，杀灭致病菌。主要用于围手术期及低免疫状态下预防感染。\u003Cspan class=\"material-ref\">[Neu HC., 1984, Rev Infect Dis]\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>给药方式：\u003C/strong>通常静脉点滴或肌肉注射，注射前需皮试及严格无菌操作。严禁自行口服。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>用药剂量：\u003C/strong>用量因年龄和肝肾功能调整，中老年需关注肾功能表现，不可随意加大剂量。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>典型副反应：\u003C/strong>过敏反应（皮疹、呼吸困难）、腹泻、肝酶异常、血小板减少。如出现皮肤瘙痒或斑疹，应立刻停药并就医。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>药物相互作用须知：\u003C/strong>不可与含钙静脉输液合用（尤其新生儿），要注意和抗凝药（如华法林）的协同出血风险。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>禁用事项：\u003C/strong>青霉素过敏患者应避免使用。曾有严重过敏史须提前告知医生。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>储存方式：\u003C/strong>配制后冷藏（2-8℃）24小时内用完。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>用药误区：\u003C/strong>误将头孢类感冒药与头孢曲松注射剂混淆，可能延误治疗或增风险。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"material-case material-case-bg\">\n      \u003Cspan>实际用药经验：\u003C/span>有患者使用头孢曲松后出现瘙痒及过敏反应，立即停药并给予抗过敏处理，症状明显缓解。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 04 胰岛素辅助的关键细节 -->\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #f9f6fb 0%, #e7edfb 100%)\">\n    \u003Ch2 class=\"material-subtitle\">\u003Cspan>04 ⏳ 胰岛素的辅助用药安全细则\u003C/span>\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cstrong>作用机制：\u003C/strong>胰岛素促进葡萄糖进入细胞、降低血糖。化疗期间用于辅助控制血糖，预防高血糖并发症。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>用药要求：\u003C/strong>多为皮下注射，餐前15-30分钟使用，注射部位应轮换。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>不良反应：\u003C/strong>低血糖较常见，表现为手抖、出汗、心悸。需定时监测血糖，如低血糖可口服糖水或点心缓解。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>药物相互作用：\u003C/strong>与某些抗生素、β-受体阻滞剂同用易掩盖低血糖症状。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>禁忌事项：\u003C/strong>对胰岛素或辅料过敏者禁用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>漏药处理：\u003C/strong>如漏服可即时补注，接近下一次剂量则不需追加。严禁重复用药预防低血糖。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>保存方式：\u003C/strong>未使用胰岛素须冷藏（2-8℃），避免冷冻，已开封可置室温，不宜超28天。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \n  \u003C!-- 05 胃黏膜保护剂合理服用 -->\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #f7f8fa 0%, #e6e7ee 100%)\">\n    \u003Ch2 class=\"material-subtitle\">\u003Cspan>05 🛡️ 胃黏膜保护剂的科学应用法则\u003C/span>\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cstrong>药理作用：\u003C/strong>促进胃黏膜屏障修复、减轻胃酸刺激，减少化疗期间胃肠反应。常用药包括氨基比林、泮托拉唑、雷贝拉唑等。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>正确使用：\u003C/strong>通常餐前或空腹服用，有的肠溶剂型务必整片吞服，不得咀嚼或溶解。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>相互作用：\u003C/strong>服药间隔需与抗真菌、抗病毒等药物错开1-2小时，防止吸收干扰。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>常见副作用：\u003C/strong>腹胀、嗳气、轻微便秘。一般症状较轻，如持续不适需重新评估是否继续服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>特殊人群需知：\u003C/strong>老人用量需降级，儿童及孕妇应慎用或遵医嘱，不应用于无食欲者。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>储存要点：\u003C/strong>常温避光保存，部分制剂需避潮。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \n  \u003C!-- 06 药物储存、有效期及安全管理 -->\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #fcfaf9 0%, #f3f7fb 80%)\">\n    \u003Ch2 class=\"material-subtitle\">\u003Cspan>06 🔐 使用期间的药品储存与安全处置\u003C/span>\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cstrong>统一原则：\u003C/strong>所有口服及注射药需保存于干燥、避光环境，严格密封。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>温度要求：\u003C/strong>口服药一般室温、注射剂冷藏，避免置于高温、阳光直射处。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>超过有效期：\u003C/strong>过期药品禁止服用，正确做法是送至医院药剂科或专门回收点处理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>安全管理：\u003C/strong>家庭药品和化疗药严格分区存放，避免儿童误食。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>特别提醒：\u003C/strong>药瓶标签勿撕毁，随时核查药品名称与用法说明，防止混淆。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \n  \u003C!-- 07 用药中的误区与应急处理 -->\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #faf9fd 0%, #f6f9fc 100%)\">\n    \u003Ch2 class=\"material-subtitle\">\u003Cspan>07 ⛑️ 用药误区和紧急处理要诀\u003C/span>\u003C/h2>\n    \u003Cul class=\"material-list\">\n      \u003Cli>\n        \u003Cstrong>漏服/错服应对：\u003C/strong>如不小心漏服，除非医生有特别叮嘱，多数药物当天适当补服；错服或重复服药，应立即报告医生，切勿自行处理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>不良反应紧急识别：\u003C/strong>出现皮疹、全身水肿、严重腹泻等，应立即就医。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>避免自作主张：\u003C/strong>用药期间发现副作用或疑似不适，必须第一时间反馈药师和医生，切忌自行停药或换药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>健康监测：\u003C/strong>静脉输注期间密切关注血压、体温、皮肤变化，定期监测血象和肝肾功能。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>安全用药小贴士：\u003C/strong>每次服药前再次核查药品包装和名称，不图省事用手抓药片、拆分剂量。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n  \n  \u003C!-- 结尾与安全提醒 -->\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #f5faff 0%, #f8f9fb 100%)\">\n    \u003Ch2 class=\"material-subtitle\">\u003Cspan>🔔 总结：牢记正确用药七大要点\u003C/span>\u003C/h2>\n    \u003Cp class=\"material-summary\">\n      综合来看，无论是靶向药瑞戈非尼，还是化疗或辅助类用药，都必须做到“适量、适时、监测、分清类别、妥善保存、避免混用和重视反应”。只要严格按专业建议操作，大多数化疗药和辅助药品都能安全有效地发挥作用。任何疑问，建议随时和专科药师或主治医生沟通，切不可自行调整方案。\u003Cbr>\n      📝 \u003Cstrong>记住：\u003C/strong>药物无小事，用药安全第一！让化疗成为“加分项”，指引健康新生活。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003C!-- 参考文献 -->\n  \u003Cdiv class=\"material-section-refer material-section\" style=\"background: #f6f7fb;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"margin-bottom:8px;\">\u003Cspan>📚 主要参考文献\u003C/span>\u003C/h2>\n    \u003Cul class=\"refer-list\">\n      \u003Cli>\n        Grothey, A., Van Cutsem, E., Sobrero, A., et al. (2013). Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomized, placebo-controlled, phase 3 trial. \u003Ci>Lancet\u003C/i>, 381(9863), 303-312. \u003Cspan class=\"material-ref\">[PMID: 23268441]\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        Van Cutsem, E., Köhne, C.H., Hitre, E., et al. (2016). Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 360(14), 1408-1417. \u003Cspan class=\"material-ref\">[PMID: 19339720]\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        Neu, H.C. (1984). Ceftriaxone: An overview. \u003Ci>Reviews of Infectious Diseases\u003C/i>, 6(Suppl 4): S530-S546. \u003Cspan class=\"material-ref\">[PMID: 6237039]\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\u003Cstyle>\n.material-medication-guide {\n  font-family: \"Segoe UI\", \"Helvetica Neue\", Helvetica, Arial, \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei\", sans-serif;\n  line-height: 1.75;\n  color: #25304a;\n  background: #f9fafd;\n  max-width: 860px;\n  margin: 0 auto;\n  box-sizing: border-box;\n  padding: 24px 20px 48px 20px;\n}\n.material-title {\n  font-size: 2.2rem;\n  font-weight: bold;\n  letter-spacing: 1px;\n  color: #336397;\n  margin-bottom: 34px;\n  padding-bottom: 18px;\n  border-bottom: 3px solid #dae5f6;\n  background: linear-gradient(90deg, #e8f0fc 75%, #f5fafc 100%);\n  text-align: center;\n}\n.material-intro {\n  font-size: 1.16rem;\n  color: #546078;\n  text-indent: 2em;\n  letter-spacing: 0.2px;\n  padding: 30px 17px 16px 17px;\n  border-radius: 18px;\n  background: none !important;\n  margin-bottom: 4px;\n}\n.material-section {\n  margin: 36px 0 0 0;\n  border-radius: 20px;\n  padding: 1em 1.1em 1.1em 1.6em;\n  box-shadow: 0 2px 16px 0 #f1f5fa;\n}\n.material-section-cover {\n  margin-top: 0 !important;\n}\n.material-subtitle {\n  font-size: 1.35rem;\n  font-weight: 600;\n  margin-bottom: 18px;\n  letter-spacing: 0.1em;\n  color: #235089;\n  padding-top: 15px;\n  padding-bottom: 8px;\n  text-shadow: 0 4px 12px #e6e7ec20;\n  background: none;\n  border-radius: 8px;\n}\n.material-list {\n  margin-left: 0;\n  padding-left: 1.6em;\n  font-size: 1.06rem;\n  color: #374057;\n  line-height: 2.1;\n}\n.material-list li {\n  margin-bottom: 0.7em;\n  padding-left: 0.2em;\n}\n.material-case {\n  margin-top: 16px;\n  margin-bottom: 6px;\n  padding: 12px 17px 10px 13px;\n  background: #f8f5eb;\n  color: #846a3a;\n  border-left: 5px solid #e5c892;\n  border-radius: 8px;\n  font-size: 1.02rem;\n  line-height: 1.7;\n}\n.material-case-bg {\n  background: #f8f1ea;\n}\n.material-summary {\n  padding: 16px 18px 14px 18px;\n  border-radius: 14px;\n  background: #f4f7fa;\n  color: #2c495f;\n  font-size: 1.12rem;\n  margin-top: 14px;\n  letter-spacing: 0.01em;\n  line-height: 1.9;\n}\n.material-section-refer {\n  margin-top: 38px !important;\n  margin-bottom: 20px;\n  background: #f6f7fb !important;\n  box-shadow: none !important;\n  border-radius: 15px;\n  padding-top: 15px !important;\n}\n.refer-list {\n  font-size: 1.01rem;\n  color: #6180a8;\n  margin: 0 0 7px 2.2em;\n  padding-left: 0.6em;\n  line-height: 1.8;\n}\n.material-ref {\n  color: #aea496;\n  font-size: 0.97em;\n  font-style: italic;\n  margin-left: 4px;\n}\n@media (max-width:700px) {\n  .material-medication-guide {\n    padding: 7px 3vw 24px 3vw;\n    max-width: 100vw;\n  }\n  .material-title { font-size: 1.45rem; }\n  .material-subtitle { font-size: 1.09rem; }\n  .material-intro, .material-summary { font-size: 1.01rem; }\n  .material-list { font-size: 0.99rem; }\n}\n\u003C/style>","\u003Cdiv class=\"material-medication-guide\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\">结肠癌ⅢC期中分化腺癌",536,"2025-10-23 19:33:02","结肠癌, 化疗用药, 瑞戈非尼, 头孢曲松, 辅助治疗, 高血糖, 药物相互作用","本指南深入解析结肠癌ⅢC期患者的化疗用药，包括瑞戈非尼、头孢曲松等关键护理信息，帮助患者及家属安全用药，避免风险。","2025-11-18 14:46:08",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]